Physician profile
Huu Vo
NPI 1811941909
$698.28
in general payments reported to CMS, 2019-2025
14 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $83.62 · 2021: $164 · 2022: $38.55 · 2023: $20.45 · 2024: $14.64 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $166.54 | 2021-2025 | |
| Ironwood Pharmaceuticals, INC | $148.99 | 2019-2021 | |
| Allergan, INC. | $91.41 | 2019-2020 | |
| Astellas Pharma US INC | $44.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.92 | 2020-2021 | |
| Vivus LLC | $38.55 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.34 | 2025 | |
| Aimmune Therapeutics, INC. | $26.75 | 2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $21.82 | 2021 | |
| Scilex Pharmaceuticals INC. | $20.45 | 2023 | Ztlido |
| Sumitomo Pharma America, INC. | $19.56 | 2025 | Gemtesa |
| Horizon Therapeutics Plc | $18.65 | 2020 | |
| Novo Nordisk INC | $18.56 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huu Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.